Endo Set to Begin Transvaginal Mesh Personal Injury Trial as Bellwether Cases Scheduled
A federal judge has set bellwether trial dates for the multidistrict litigation against Endo Pharmaceuticals and their transvaginal mesh devices.
American Medical Systems, the transvaginal mesh subsidiary of Endo, faces at least 16,000 personal injury cases involving failed transvaginal mesh devices and their side effects. Although the company settled a few of the transvaginal mesh injury cases out of court last year, the majority of the cases still await a verdict.
Two bellwether cases have been scheduled – one will begin on June 2nd, 2014, and the other will begin on July 7th.
Last June, Endo announced that it would settle several of the transvaginal mesh injury cases, paying out $54.5 million to the plaintiffs. The company added that it “intend[ed] to continue to vigorously defend themselves in the remaining mesh product liability cases and in any new cases that may arise,” company officials said in the filing with the U.S. Securities and Exchange Commission.
Endo Sets Aside $520 Million for Transvaginal Mesh Litigation
The medical manufacturer reported in February that it had set aside $520 million to settle the remaining transvaginal mesh lawsuits, although so far the company has not proposed that settlement amount in court.
A securities filing from the company noted that Endo had increased its product liability pool to $520 million at the end of last year.
“The increase in our reserve reflects management’s ongoing assessment of our product liability portfolio, including the vaginal mesh cases, the status of the company’s ongoing settlement discussions related to vaginal mesh litigation and the inherent uncertainty as to the ultimate costs of resolving this litigation,” Endo said.
Endo officials also stated that the amount would cover not only settlement deals, but judgments and legal defense related to the transvaginal mesh lawsuits.
The Strom Law Firm Represents Women in Transvaginal Mesh Personal Injury Cases
Transvaginal mesh was originally developed in 1996 and approved by the FDA for organ prolapse that caused vaginal pain and stress urinary incontinence. The original transvaginal mesh, Boston Scientific’s ProtoGen, was recalled in 1999, but due to an FDA approval loophole called 510(k) – which fast-tracks approval of devices similar to previously-approved devices – many other medical manufacturing companies began developing transvaginal mesh devices of their own.
Recently, due to the high number of personal injury claims involving transvaginal mesh devices, CR Bard, Endo Health Solutions, Boston Scientific, Coloplast, and Cook Medical, began settlement talks. Reportedly, these five transvaginal mesh manufacturers faced a total of 30,000 personal injury lawsuits. Johnson & Johnson, meanwhile, has not agreed to any settlement talks and will continue facing bellwether trials in its MDL in Virginia.
It is important to hold medical manufacturers, including manufacturers of transvaginal mesh, to the highest ethical standard. If you or a loved one have had surgery involving transvaginal mesh, and have since suffered painful side effects including bleeding, infection, organ perforation, and constant pain in the lower extremities, you may be entitled to compensation. The attorneys at the Strom Law Firm understand the suffering caused by defective devices like transvaginal mesh, and can help with your case. We offer free, confidential consultations to discuss your concerns, so do not hesitate to contact us. 803.252.4800.